Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0CVQVO)
| ADC Name |
CN115594732A II-LD-017
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
II-LD-017
Click to Show/Hide
|
|||||
| Organization |
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO LTD; Taizhou Fudan Zhangjiang Pharmaceutical Co Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.9
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||